Protandim, a fundamentally new antioxidant approach in chemoprevention using mouse two-stage skin carcinogenesis as a model.
Oxidative stress is an important contributor to cancer development. Consistent with that, antioxidant enzymes have been demonstrated to suppress tumorigenesis when being elevated both in vitro and in vivo, making induction of these enzymes a more potent approach for cancer prevention. Protandim, a well-defined combination of widely studied medicinal plants, has been shown to induce superoxide dismutase (SOD) and catalase activities and reduce superoxide generation and lipid peroxidation in healthy human subjects. To investigate whether Protandim can suppress tumor formation by a dietary approach, a two-stage mouse skin carcinogenesis study was performed. At the end of the study, the mice on a Protandim-containing basal diet had similar body weight compared with those on the basal diet, which indicated no overt toxicity by Protandim. After three weeks on the diets, there was a significant increase in the expression levels of SOD and catalase, in addition to the increases in SOD activities. Importantly, at the end of the carcinogenesis study, both skin tumor incidence and multiplicity were reduced in the mice on the Protandim diet by 33% and 57% respectively, compared with those on basal diet. Biochemical and histological studies revealed that the Protandim diet suppressed tumor promoter-induced oxidative stress (evidenced by reduction of protein carbonyl levels), cell proliferation (evidenced by reduction of skin hyperplasia and suppression of PKC/JNK/Jun pathway), and inflammation (evidenced by reduction of ICAM-1/VCAM-1 expression, NF-kappaB binding activity, and nuclear p65/p50 levels). Overall, induction of antioxidant enzymes by Protandim may serve as a practical and potent approach for cancer prevention.
Liu
Jianfeng
J
Department of Pharmacology, Toxicology & Neuroscience, Louisiana State University Health Sciences Center, Shreveport, Louisiana, United States of America.
Gu
Xin
X
Robbins
Delira
D
Li
Guohong
G
Shi
Runhua
R
McCord
Joe M
JM
Zhao
Yunfeng
Y
D000818:Animals; D000975:Antioxidants / Q000008:administration & dosage / Q000494:pharmacology*; D015153:Blotting, Western; D002471:Cell Transformation, Neoplastic; D004032:Diet; D004365:Drugs, Chinese Herbal / Q000008:administration & dosage / Q000494:pharmacology*; D024202:Electrophoretic Mobility Shift Assay; D004790:Enzyme Induction; D005260:Female; D051379:Mice; D008811:Mice, Inbred DBA; D018384:Oxidative Stress / Q000187:drug effects; D012878:Skin Neoplasms / Q000517:prevention & control*; D013482:Superoxide Dismutase / Q000096:biosynthesis
D000975:Antioxidants; D004365:Drugs, Chinese Herbal; C509374:Protandim; D013482:Superoxide Dismutase